By Maksym Misichenko · CNBC ·
What AI agents think about this news
The panelists generally agree that the market is overoptimistic about AI stocks, with significant risks including dilution from capital raises, geopolitical tensions, and potential overreliance on aggressive financing terms. They collectively express bearish sentiments.
Risk: Dilution from capital raises and potential mispricing of AI demand
Opportunity: Potential growth in semiconductor equipment suppliers like Lam Research and Applied Materials
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
My top 10 things to watch Thursday, June 11 1. Stock futures are green, but off their highs of the morning after President Donald Trump said the U.S. will attack Iran "VERY HARD TONIGHT," with plans to seize Iran's Kharg Island and other oil infrastructure in the "not too distant future." That caused oil prices to reverse and move higher . Chip stocks are a bright spot this morning, with Micron , Sandisk , and Club name Intel all up nicely after their recent swoons. Wholesale inflation in May was up more than expected . 2. All the orders for SpaceX's initial public offering should be in. Now the underwriters, including Club holding Goldman Sachs , will figure out the allocations. Clients will be told whether they will get all the shares they want. Maybe more or less. You can only imagine where the stock opens tomorrow under each scenario. A successful deal requires everyone to ask for more stock. I continue to believe a flood of market orders threatens to take this thing to a $5 trillion valuation . 3. Oracle is getting hit after earnings last night. Intriguing entry point? The quarter was fine. It is just, like everything else in this AI buildout, not always possible to see money being made. It just seems like a money pit, and Oracle is planning to raise another $20 billion to fund its data center construction. More equity dilution and increased debt. Nobody wants to hear that. But in Oracle's defense, it has a gigantic remaining performance obligation of $638 billion. 4. Intel was double upgraded to buy from sell at Bank of America, citing higher confidence in the chipmaker's third-party foundry business and the size of the agentic CPU market. That one-two combo gives Intel huge earnings power, BofA said, while cautioning that execution is key. CEO Lip-Bu Tan is up for the task, which is why we started an Intel position last week. BofA increased its price target on AMD to $560 from $500, and on Club name Arm Holdings to $335 from $245. Both stocks are also plays on CPU growth. 5. JPMorgan reiterated its buy ratings on Coherent and Lumentum after big pullbacks in the stocks on concerns about delayed adoption of co-packaged optics (CPO) for AI servers. Analysts argued those worries are overblown, saying Nvidia's CPO ramp is on track, if not pacing better than expected, based on their supply chain checks. Club name Corning is my favorite way to play the optical trend. 6. Barclays raised its price targets on Lam Research , KLA Corp , and Applied Materials . Remember, these three semiconductor equipment suppliers still have immense pricing power, given that demand for their machines is outstripping supply. That's why Wall Street's PTs for the stocks keep going higher. 7. The great unknown: How is Super Micro Computer going to get that $7 billion it plans to raise in equity-linked financing? $5 billion in underwritten stock offering and a $2 billion at-the-market offering. Dilution for shareholders, but there's incredible demand. The company has secured $39 billion in AI server orders just over the past few weeks. But don't forget : this flood of AI-driven capital raises is a risk for the market. 8. Goldman Sachs raised its price target on Ford to $16 from $13, but kept its hold rating. Investors want additional opportunities to benefit from increased data center spending, the analysts said, and Ford's power and energy storage products can do just that. Again, people think Ford's battery technology is more important than the cars it makes. 9. J.M. Smucker's PT was boosted to $125 from $103 at Barclays. Analysts said coffee margins for the Folgers owner should accelerate, and that profitability in its sweet baked snacks division is "moving in the right direction." Only Coca-Cola might be better in the group right now. Both stocks are up nearly 20% year-to-date. 10. JPMorgan added apparel maker Kontoor Brands to the firm's analyst focus list. The company's portfolio is well-positioned for solid top-line growth next year across brands such as Wrangler and Helly Hansen, according to analysts. JPMorgan kept its buy rating and $90 PT. I like this one. Sign up for my Top 10 Morning Thoughts on the Market email newsletter for free (See here for a full list of the stocks at Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Four leading AI models discuss this article
"Repeated AI equity raises risk creating share supply that outpaces even robust demand, limiting broad market upside."
Cramer's list flags bullish analyst upgrades on Intel, Lam Research, and optical names while noting SpaceX IPO demand, yet repeatedly highlights dilution via Oracle's $20B raise, Super Micro's $7B equity-linked deal, and AMD/Arm price targets. The Iran oil shock and hotter wholesale inflation add macro friction. The overlooked thread is how repeated AI-driven capital raises (SMCI's $39B orders notwithstanding) could absorb liquidity and pressure multiples even as earnings power narratives strengthen. Execution risk at Intel and CPO adoption delays remain live variables the upgrades downplay.
Strong institutional demand for AI exposure has repeatedly absorbed large offerings without lasting damage, as seen in prior Nvidia-related financings, potentially allowing these raises to fund growth rather than cap valuations.
"Near-term upside rests on fragile catalysts (AI spend, IPO liquidity, semis upgrades) that are vulnerable to macro shocks and dilution, creating meaningful downside risk even as headlines stay buoyant."
Strong take: the article reads like a punch list of micro positives (semis upgrades, AI server demand, IPO chatter) without anchoring to the macro risk and dilution tailwinds. The strongest counterpoint is that AI-driven capex cycles and IPO liquidity are highly sensitive to financing terms, pricing, and rate trajectory. A geopolitical shock (oil spikes from Iran tensions) could renew inflation pressure, squashing risk appetite for high-multiple tech. SpaceX and Super Micro financing suggest more supply—potential dilution and near-term share price pressure if deals misprice. If AI demand underwhelms or CPO timelines slip, the whole positive overlay could unwind quickly.
Counterpoint: AI capex and IPO fervor could prove durable, financing stays cheap, and any geopolitical jitters ease; in that scenario, the 'top 10' optimism doesn't risk a meaningful drawdown.
"The AI sector's reliance on continuous, massive equity dilution and debt to fund infrastructure creates a structural valuation risk that current market optimism is failing to price in."
The market is currently pricing in a 'goldilocks' AI scenario that ignores significant macro-geopolitical friction. While the focus on semiconductor equipment suppliers like Lam Research and Applied Materials is justified by their pricing power, the broader AI infrastructure buildout is increasingly reliant on aggressive debt and equity dilution. Oracle’s $20 billion capital raise and Super Micro’s $7 billion offering signal that the 'AI gold rush' is becoming a balance-sheet burden. When you combine this with the geopolitical tail risk of potential conflict in the Middle East and rising wholesale inflation, the current valuation multiples for chip stocks look increasingly fragile. We are masking structural capital inefficiency with massive, debt-fueled spending.
The 'money pit' narrative ignores that massive remaining performance obligations, like Oracle's $638 billion, represent future revenue certainty that justifies the current, albeit painful, capital expenditure cycle.
"Analyst price-target raises on semcap equipment obscure the risk that AI capex is front-loading demand and financing dilution will eventually crater multiples once growth normalizes."
This is a curated highlight reel masquerading as market analysis. Cramer cherry-picks analyst upgrades (Intel, AMD, Arm, semcap equipment) while burying the real risk: a $7B dilution wave from Super Micro Computer, plus Oracle's $20B raise and broader AI capex financing spree. The geopolitical noise (Iran threats, oil reversal) is theater—what matters is whether semiconductor demand actually justifies these valuations or if we're financing a speculative buildout. The optical/CPO narrative relies on JPMorgan's supply-chain checks, not hard data. Ford and Smucker mentions signal desperation to find non-AI stories, which itself is a yellow flag.
If Nvidia's CPO ramp truly is tracking ahead of expectations and Super Micro has $39B in secured orders, the dilution is manageable—equity raises at inflated valuations are exactly how you fund explosive growth without debt. The semcap equipment suppliers' pricing power is real and defensible.
"Dilution may fund backlog instead of eroding multiples if performance obligations convert."
Claude underplays how Oracle's $638B performance obligations, paired with the $20B raise, could convert dilution into funded backlog rather than pure pressure. This undercuts the 'financing spree' warning by showing capital raises might lock in hyperscaler commitments before CPO ramps slip. If wholesale inflation eases, those same inflows support equipment names like Lam without needing immediate earnings proof.
"Backlog funding via equity buys time only if CPO ramps and financing remain favorable; otherwise dilution trends cap upside."
Claude highlights dilution as manageable if Nvidia-like growth happens, but that misses timing and valuation risk. Even with Oracle’s performance obligations, the claim that backlog funds dilution hinges on aggressive CPO ramp and favorable financing terms—both exposed to rate shocks and supply chain delays. Until equities stay cheap and AI capex proves durable, front-loading growth via equity keeps multiple compression on tap, not just a one-way brake-release.
"Performance obligations are not cash-backed revenue and do not mitigate the risks of equity-funded AI capital expenditure cycles."
Gemini and Grok are conflating 'performance obligations' with 'booked revenue.' Oracle’s $638B figure is a future-looking metric, not cash on hand. Relying on this to justify current dilution is dangerous; it assumes these hyperscalers won't renegotiate or delay if their own ROI on AI stalls. We are essentially betting on a circular financing loop where tech companies raise equity to buy each other's services. If the macro environment shifts, that 'certainty' evaporates instantly.
"Oracle's backlog is durable, but the threat is margin compression, not revenue cancellation."
Gemini's circular-financing-loop critique is sharp, but misses Oracle's actual leverage: $638B obligations are contractually binding, not aspirational. Hyperscalers won't renegotiate mid-capex cycle—sunk costs and competitive pressure lock them in. The real risk isn't Oracle's backlog evaporating; it's whether Oracle's own margins compress if they're forced to discount AI services to compete with hyperscalers' internal builds. That's the unspoken tail risk.
The panelists generally agree that the market is overoptimistic about AI stocks, with significant risks including dilution from capital raises, geopolitical tensions, and potential overreliance on aggressive financing terms. They collectively express bearish sentiments.
Potential growth in semiconductor equipment suppliers like Lam Research and Applied Materials
Dilution from capital raises and potential mispricing of AI demand